La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Brain (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Brain (diagnostic imaging) < Brain (drug effects) < Brain (embryology)  Facettes :

List of bibliographic references indexed by Brain (drug effects)

Number of relevant bibliographic references: 46.
[0-20] [0 - 20][0 - 46][20-40]
Ident.Authors (with country if any)Title
000284 (2016) Enkhjargal Bayarsaikhan [Corée du Sud, Mongolie] ; Delger Bayarsaikhan [Corée du Sud] ; Jaesuk Lee [Corée du Sud] ; Myeongjoo Son [Corée du Sud] ; Seyeon Oh [Corée du Sud] ; Jeongsik Moon [Corée du Sud] ; Hye-Jeong Park [Corée du Sud] ; Arivazhagan Roshini [Corée du Sud] ; Seung U. Kim [Canada] ; Byoung-Joon Song [États-Unis] ; Seung-Mook Jo [Corée du Sud] ; Kyunghee Byun [Corée du Sud] ; Bonghee Lee [Corée du Sud]Microglial AGE-albumin is critical for neuronal death in Parkinson’s disease: a possible implication for theranostics
000488 (2015) Janelle Drouin-Ouellet ; Isabelle St-Amour ; Martine Saint-Pierre ; Jérôme Lamontagne-Proulx ; Jasna Kriz ; Roger A. Barker ; Francesca CicchettiToll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson’s Disease
000519 (2015) Ulf Ziemann [Allemagne] ; Janine Reis [Allemagne] ; Peter Schwenkreis [Allemagne] ; Mario Rosanova [Italie] ; Antonio Strafella [Canada] ; Radwa Badawy [Australie] ; Florian Müller-Dahlhaus [Allemagne]TMS and drugs revisited 2014.
000570 (2015) Y. Wang [Canada] ; Z. Zhou [Canada] ; T. Leylek [Canada] ; H. Tan [Canada] ; Y. Sun [Canada] ; F E Parkinson [Canada] ; J-F Wang [Canada]Protein cysteine S-nitrosylation inhibits vesicular uptake of neurotransmitters.
000678 (2015) Ross B. Mounsey [Royaume-Uni] ; Sarah Mustafa [Royaume-Uni] ; Lianne Robinson [Royaume-Uni] ; Ruth A. Ross [Canada] ; Gernot Riedel [Royaume-Uni] ; Roger G. Pertwee [Royaume-Uni] ; Peter Teismann [Royaume-Uni]Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
000786 (2015) Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.
000B26 (2014) Silke Appel-Cresswell [Canada] ; Ali H. Rajput ; Vesna Sossi ; Christina Thompson ; Vanessa Silva ; Jessamyn Mckenzie ; Katherine Dinelle ; Siobhan E. Mccormick ; Carles Vilari O-Güell ; A Jon Stoessl ; Dennis W. Dickson ; Chris A. Robinson ; Matthew J. Farrer ; Alex RajputClinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism.
000C97 (2013) Matthew P. Mount ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. ParkPerturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)*
000D34 (2013) Pierre O. Poliquin [Canada] ; Jingkui Chen [Canada] ; Mathieu Cloutier [Canada] ; Louis-Éric Trudeau [Canada] ; Mario Jolicoeur [Canada]Metabolomics and In-Silico Analysis Reveal Critical Energy Deregulations in Animal Models of Parkinson’s Disease
000D83 (2013) Maria Gabriela Sánchez [Canada] ; Marc Morissette ; Thérèse Di PaoloEstradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.
000D87 (2013) R. Abdalian [Canada] ; O. Saqui ; G. Fernandes ; J P AllardEffects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition.
000D99 (2013) Francesca Antonelli [Canada] ; Ji Hyun Ko [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Franco Valzania [Italie] ; Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada]Dopamine-Agonists and Impulsivity in Parkinson’s Disease: Impulsive Choices vs. Impulsive Actions
000E37 (2013) Golnasim Riahi ; Marc Morissette ; Pershia Samadi ; Martin Parent ; Thérèse Di PaoloBasal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
001191 (2012) Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. BrotchieL-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001A25 (2010) Wing-Lok Au [Singapour] ; Ni Lei ; Meeko M K. Oishi ; Martin J. MckeownL-dopa induces under-damped visually guided motor responses in Parkinson's disease.
001A51 (2010) Qingjia Meng [Canada] ; Dirk W. Luchtman ; Bouchaib El Bahh ; Jeffrey A. Zidichouski ; Jun Yang ; Cai SongEthyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices.
001C23 (2010) Bernard Ng [Canada] ; Samantha Palmer [Canada] ; Rafeef Abugharbieh [Canada] ; Martin J. Mckeown [Canada]Focusing effects of L‐dopa in Parkinson's disease
002081 (2009) Pershia Samadi [Canada] ; Alex Rajput [Canada] ; Frédéric Calon [Canada] ; Laurent Gregoire [Canada] ; Oleh Homykiewicz [Canada, Autriche] ; Ali H. Rajput [Canada] ; Thèrèse Di Paolo [Canada]Metabotropic Glutamate Receptor II in the Brains of Parkinsonian Patients
002088 (2009) S. J. Palmer [Canada] ; L. Eigenraam [Canada] ; T. Hoque [Canada] ; R. G. Mccaig [Canada] ; A. Troiano [Canada] ; M. J. Mckeown [Canada]LEVODOPA-SENSITIVE, DYNAMIC CHANGES IN EFFECTIVE CONNECTIVITY DURING SIMULTANEOUS MOVEMENTS IN PARKINSON'S DISEASE
002202 (2008) Junning Li [Canada] ; Z Jane Wang ; Samantha J. Palmer ; Martin J. MckeownDynamic Bayesian network modeling of fMRI: a comparison of group-analysis methods.
002212 (2008) Jiang Yue [Canada] ; Sharon Miksys ; Ewa Hoffmann ; Rachel F. TyndaleChronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Brain (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Brain (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Brain (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022